ENDURANCE-3: safety and efficacy of glecaprevir/pibrentasvir compared to sofosbuvir plus daclatasvir in treatment-naive HCV genotype 3-infected patients without cirrhosis
Publication Type:
Journal Article
Authors:
Foster, G.R.;
Gane, E.;
Asatryan, A.;
Asselah, T.;
Ruane, P.J.;
Pol, S.;
Poordad, F.;
Stedman, C.A.;
Dore, G.;
Roberts, S.K.;
Kaita, K.;
Vierling, J.;
Vargas, H.E.;
Kort, J.;
Lin, C.-W.;
Liu, R.;
Ng, T.;
Mensa, F.Source:
J Hepatol, Volume 66, Issue 1, p.S33 (2017)
URL:
http://dx.doi.org/10.1016/S0168-8278(17)30326-4
